Hospital
Mission Hospital Regional Medical Center
Mission Hospital Regional Medical Center was paid $690K by Medicaid between Jan 2018 and Nov 2024, across 219 billing codes. Its largest line is A0429, emergency ambulance ride, basic life support — 49% of everything it billed.
33Billing provider infoMISSION HOSPITAL REGIONAL MEDICAL CENTER
MISSION VIEJO, CA 92691
MISSION VIEJO, CA 92691
33aNPI1992752315assigned 05/30/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$690K
24GClaims267,395
24DCodes billed219
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#283 of 410
Median peer was paid$6.90M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,290 | $82K | |
| 2019 | 73,300 | $388K | |
| 2020 | 66,806 | $104K | |
| 2021 | 20,552 | $47K | |
| 2022 | 15,223 | $24K | |
| 2023 | 11,485 | $40K | |
| 2024incomplete | 1,739 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 49% | 5,944 | 3,312 | $335K |
| G0378 | Hospital observation service, per hour | 12% | 258 | 176 | $81K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.4% | 3,883 | 3,088 | $44K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.5% | 2,647 | 2,440 | $17K |
| 96376 | 2.5% | 2,691 | 1,592 | $17K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 3,549 | 3,189 | $16K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.1% | 1,284 | 1,048 | $15K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 6,159 | 5,037 | $11K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 6,832 | 5,829 | $10K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 1.4% | 714 | 661 | $9K |
| 0450 | Emergency room services | 1.3% | 11,449 | 9,668 | $9K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.2% | 1,356 | 1,245 | $8K |
207 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 9,110 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,218 | $6K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 747 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,247 | $4K |
| 80053 | Comprehensive metabolic panel | <1% | 8,331 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,904 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,265 | $4K |
| J3490 | Unclassified drugs | <1% | 17,670 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,324 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 441 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,325 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,600 | $3K |
| 71250 | <1% | 219 | $3K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 672 | $3K |
| 84484 | <1% | 6,682 | $2K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 100 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,057 | $2K |
| 83880 | <1% | 3,411 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,204 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,713 | $2K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 511 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,695 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,614 | $2K |
| 0250 | <1% | 3,880 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,942 | $2K |
| 76641 | <1% | 997 | $2K | |
| 82553 | <1% | 4,028 | $2K | |
| 72141 | <1% | 287 | $1K | |
| 77066 | Tomosynthesis, mammo | <1% | 407 | $1K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 103 | $1K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 178 | $1K |
| 77065 | Tomosynthesis, mammo | <1% | 388 | $1K |
| 82550 | <1% | 4,522 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 791 | $994.61 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,809 | $965.88 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 107 | $907.88 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 279 | $902.40 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,490 | $855.76 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,613 | $795.13 |
| 76830 | Ultrasound, transvaginal | <1% | 1,376 | $792.10 |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 181 | $789.98 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 689 | $784.42 |
| 97162 | <1% | 59 | $718.78 | |
| 83690 | <1% | 5,021 | $716.66 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,906 | $701.07 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,309 | $696.75 |
| C9399 | Unclassified drugs or biologicals | <1% | 17 | $672.09 |
| 76770 | <1% | 180 | $589.29 | |
| 83735 | <1% | 3,242 | $588.77 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 169 | $568.30 |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 44 | $539.76 |
| 0270 | <1% | 6,374 | $526.46 | |
| 81001 | <1% | 4,499 | $520.93 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 63 | $498.51 |
| 93971 | <1% | 216 | $494.90 | |
| 82947 | <1% | 2,017 | $477.18 | |
| 82077 | <1% | 19 | $476.57 | |
| 85610 | <1% | 4,331 | $449.67 | |
| 72131 | <1% | 60 | $441.59 | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,535 | $429.15 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,517 | $414.57 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 701 | $395.46 |
| 99153 | Mod sedat endo service >5yrs | <1% | 17 | $381.24 |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 225 | $372.55 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 37 | $364.86 |
| 84145 | <1% | 824 | $360.93 | |
| 80047 | <1% | 1,457 | $352.98 | |
| 86900 | <1% | 1,674 | $345.21 | |
| 94760 | <1% | 1,475 | $326.57 | |
| 81003 | <1% | 4,902 | $320.96 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 471 | $315.03 |
| 87040 | <1% | 1,021 | $310.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 45 | $301.90 |
| 85730 | <1% | 2,646 | $300.01 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,682 | $293.96 |
| 72100 | <1% | 574 | $293.77 | |
| 0360 | <1% | 187 | $292.34 | |
| 86901 | <1% | 1,677 | $292.27 | |
| 83605 | <1% | 1,388 | $290.87 | |
| 86850 | <1% | 1,188 | $285.80 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 42 | $276.31 |
| 80076 | <1% | 1,462 | $264.50 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 746 | $264.35 |
| 59025 | Fetal non-stress test | <1% | 797 | $261.60 |
| 72146 | <1% | 15 | $252.65 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,023 | $233.57 |
| 82150 | <1% | 1,346 | $232.62 | |
| 73030 | <1% | 393 | $231.16 | |
| 73630 | <1% | 361 | $228.66 | |
| 84703 | <1% | 2,721 | $225.58 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 143 | $224.12 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 196 | $221.03 |
| 73562 | <1% | 306 | $210.69 | |
| 85379 | <1% | 818 | $207.87 | |
| 85027 | <1% | 935 | $195.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 667 | $190.15 |
| 90715 | <1% | 196 | $184.95 | |
| 73610 | <1% | 280 | $178.74 | |
| 84702 | <1% | 1,155 | $176.88 | |
| 84100 | <1% | 575 | $170.29 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 536 | $155.80 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 302 | $141.01 |
| 93970 | <1% | 35 | $127.53 | |
| J2704 | Injection, propofol, 10 mg | <1% | 590 | $122.36 |
| 93017 | <1% | 63 | $118.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 126 | $111.38 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,765 | $105.30 |
| 87081 | <1% | 689 | $103.74 | |
| 0258 | <1% | 1,820 | $96.61 | |
| 73130 | <1% | 135 | $94.27 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 362 | $90.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 380 | $78.62 |
| 87186 | <1% | 485 | $76.45 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 377 | $70.03 |
| 73110 | <1% | 40 | $59.86 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 216 | $57.86 |
| 70486 | <1% | 52 | $56.66 | |
| 84439 | <1% | 150 | $55.31 | |
| 0710 | <1% | 305 | $52.26 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 91 | $48.13 |
| 77080 | <1% | 254 | $44.58 | |
| 87077 | <1% | 273 | $41.73 | |
| 86141 | <1% | 144 | $40.46 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 190 | $37.89 |
| 73221 | <1% | 13 | $33.82 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 419 | $32.29 |
| 94664 | <1% | 49 | $28.80 | |
| 81025 | <1% | 464 | $28.73 | |
| 96367 | <1% | 21 | $27.10 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 501 | $26.35 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 184 | $26.13 |
| 85007 | <1% | 510 | $19.16 | |
| 74018 | <1% | 128 | $17.80 | |
| 80061 | Lipid panel | <1% | 42 | $17.16 |
| 86140 | <1% | 502 | $16.97 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 87 | $16.44 |
| 97116 | <1% | 47 | $16.31 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 73 | $15.03 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 92 | $14.21 |
| 87430 | <1% | 25 | $13.58 | |
| 85652 | <1% | 456 | $13.37 | |
| 82728 | <1% | 31 | $12.74 | |
| 0637 | <1% | 1,947 | $12.25 | |
| 73590 | <1% | 12 | $11.73 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 98 | $10.86 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 30 | $10.57 |
| 73502 | <1% | 16 | $8.21 | |
| A9270 | Non-covered item or service | <1% | 4,152 | $7.96 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 108 | $7.82 |
| 87205 | <1% | 107 | $6.84 | |
| 73564 | <1% | 28 | $6.42 | |
| 87070 | <1% | 43 | $6.01 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 24 | $6.00 |
| 72040 | <1% | 13 | $5.92 | |
| 85014 | <1% | 75 | $5.54 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 45 | $4.15 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 40 | $3.98 |
| 87147 | <1% | 14 | $3.13 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $2.45 |
| 82248 | <1% | 40 | $1.46 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 2,517 | $0.09 |
| 80050 | General health panel | 0% | 68 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 71 | $0.00 |
| 0324 | 0% | 173 | $0.00 | |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 0% | 90 | $0.00 |
| 76801 | 0% | 76 | $0.00 | |
| 0761 | 0% | 284 | $0.00 | |
| 0420 | 0% | 188 | $0.00 | |
| 0301 | 0% | 1,269 | $0.00 | |
| 97010 | 0% | 618 | $0.00 | |
| 0610 | 0% | 36 | $0.00 | |
| 97139 | 0% | 189 | $0.00 | |
| 0307 | 0% | 117 | $0.00 | |
| 0305 | 0% | 211 | $0.00 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 16 | $0.00 |
| 0352 | 0% | 147 | $0.00 | |
| 0636 | 0% | 225 | $0.00 | |
| 0310 | 0% | 35 | $0.00 | |
| 0306 | 0% | 312 | $0.00 | |
| 76536 | 0% | 14 | $0.00 | |
| 0949 | 0% | 85 | $0.00 | |
| 0612 | Calcium glucon (wg critical) | 0% | 46 | $0.00 |
| 0350 | 0% | 33 | $0.00 | |
| 0401 | 0% | 68 | $0.00 | |
| 71020 | 0% | 52 | $0.00 | |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 0% | 63 | $0.00 |
| 0762 | 0% | 580 | $0.00 | |
| 77062 | 0% | 346 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 16 | $0.00 |
| 0300 | 0% | 720 | $0.00 | |
| 0160 | 0% | 128 | $0.00 | |
| 77061 | 0% | 114 | $0.00 | |
| 0351 | 0% | 85 | $0.00 | |
| 0302 | 0% | 70 | $0.00 | |
| 0760 | 0% | 101 | $0.00 | |
| 0272 | 0% | 569 | $0.00 | |
| 0361 | 0% | 26 | $0.00 | |
| 76813 | 0% | 46 | $0.00 | |
| 0403 | 0% | 92 | $0.00 | |
| 71010 | 0% | 93 | $0.00 | |
| 0278 | 0% | 38 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 53 | $0.00 |
| G0204 | Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral | 0% | 13 | $0.00 |
| 0320 | 0% | 174 | $0.00 | |
| 0402 | 0% | 249 | $0.00 | |
| 0460 | 0% | 29 | $0.00 | |
| 97799 | 0% | 182 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.